Real-World Experience Using Tafasitamab Plus Lenalidomide and/or Loncastuximab Tesirine in a Predominately Hispanic Population with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

被引：0
|
作者：
Latiolais, Heidi [1 ]
Horowitz, Justin [1 ]
Michalek, Joel [2 ]
Duque, Adolfo Enrique Diaz [1 ]
机构：
[1] Univ Texas Hlth San Antonio, MD Anderson Canc Ctr, San Antonio, TX USA
[2] Univ Texas Hlth San Antonio, Dept Populat Hlth Sci, San Antonio, TX USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-207515
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：7780 / 7781
页数：2
相关论文
共 50 条
  • [31] Health-Related Quality of Life, Symptoms, and Tolerability of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Spira, Alexander
    Zhou, Xiaolei
    Chen, Lei
    Gnanasakthy, Ari
    Wang, Luqiang
    Ungar, David
    Curiel, Rafael
    Liao, Laura
    Radford, John
    Kahl, Brad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (03): : 158 - 168
  • [32] In relapsed or refractory diffuse large B-cell lymphoma, CD19 expression by immunohistochemistry alone is not a predictor of response to loncastuximab tesirine
    Caimi, Paolo F.
    Hamadani, Mehdi
    Carlo-Stella, Carmelo
    Nickaeen, Masoud
    Jordie, Eric
    Utsey, Kiersten
    Knab, Tim
    Zammarchi, Francesca
    Cucchi, Danilo
    Pantano, Serafino
    Havenith, Karin
    Wang, Ying
    Boni, Joseph
    EJHAEM, 2024, 5 (01): : 76 - 83
  • [33] Long-Term Survival Projections of Loncastuximab Tesirine-Treated Patients in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Hamadani, Mehdi
    Graham, Christopher
    Liao, Laura
    Zhang, Kate
    Strat, Hannah
    Ungar, David
    Ai, Weiyun
    Chen, Lei
    Carlo-Stella, Carmelo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S373 - S373
  • [34] Real-world practice patterns and outcomes in Veterans with relapsed/refractory diffuse large B-cell lymphoma
    Chien, Hsu-Chih
    Morreall, Deborah
    Patil, Vikas
    Rasmussen, Kelli M.
    Li, Chungyang
    Yong, Christina M.
    Burningham, Zachary
    Masaquel, Anthony
    Halloran, Mary
    De Long-Sieg, Elisha
    Schulz, Mathias
    Sauer, Brian C.
    Halwani, Ahmad S.
    FUTURE ONCOLOGY, 2020, 17 (04) : 411 - 422
  • [35] Early and Sustained Circulating Tumor DNA Response Dynamics after Loncastuximab Tesirine for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Kurtz, David M.
    Hogan, Gregory
    Schultz, Andre
    Chabon, Jacob J.
    Alizadeh, Ash A.
    Havenith, Karin
    Samari, Sara
    Kopotsha, Tim
    Wang, Luqiang
    Qin, Yajuan
    Wang, Ying
    Pantano, Serafino
    BLOOD, 2023, 142
  • [36] Estimates of Survival and Life Expectancy with Tafasitamab Plus Lenalidomide in the L-Mind Study Compared with Real-World Standard- of-Care for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Duell, Johannes
    Dreyling, Martin
    Gaidano, Gianluca
    Kalakonda, Nagesh
    Gonzalez Barca, Eva Maria
    Liberati, Anna Marina
    Nagy, Zsolt
    Moik, Daniel
    Vukcevic, Mirko
    Amin, Aasim
    Bakuli, Abhishek
    BLOOD, 2023, 142
  • [37] Tafasitamab in refractory diffuse large B-cell lymphoma with neurolymphomatosis
    Mendes, Joao Ricardo Belo Freitas
    Couleur, Laurine
    Manca, Chloe
    Frossard, Valerie
    Nabergoj, Mitja
    ANNALS OF HEMATOLOGY, 2025, 104 (02) : 1291 - 1293
  • [38] Efficacy and safety of lenalidomide in relapsed/refractory diffuse large B-cell lymphoma
    Habermann, T.
    Lossos, I.
    Justice, G.
    Tuscano, J.
    Cole, C.
    Vose, J.
    Pietronigro, D.
    Takeshita, K.
    Ervin-Haynes, A.
    Zeldis, J.
    Wiernik, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 150 - 150
  • [39] [18F]FDG PET/CT biomarkers in patients with Relapsed/ Refractory Diffuse Large B-cell Lymphoma treated with Loncastuximab tesirine
    Zanca, R.
    Improta, C. M.
    Magagnoli, M.
    Mazza, R.
    Rodari, M.
    Carlo-Stella, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S579 - S579
  • [40] Real-world experience of CAR T-cell therapy in older patients with relapsed/refractory diffuse large B-cell lymphoma
    Chihara, Dai
    Liao, Laura
    Tkacz, Joseph
    Franco, Anjali
    Lewing, Benjamin
    Kilgore, Karl M.
    Nastoupil, Loretta J.
    Chen, Lei
    BLOOD, 2023, 142 (12) : 1047 - 1055
12345